Power Grid Q3 Results: The PSU’s net profit dropped four per cent to ₹3,861.6 crore dragged by weak demand in the third ...

Power Grid Corporation of India reported a 4% drop in its consolidated net profit for the December 2024 quarter, totaling Rs ...

Shares of Power Grid Corporation of India dropped 3.6% after reporting a 4% decline in consolidated net profit for the ...

Power Grid Corporation of India's net profit fell 4% to Rs 3,861.63 crore in the December 2024 quarter, with total income ...

Like a good driver, the Scottsdale Transportation Commission looked far ahead — and checked the rearview mirror. The Jan. 16 first meeting of the year for the volunteer commission unveiled a new ...

Power Grid Corporation of India reported a 4% year-on-year decline in net profit for the December 2024 quarter to Rs 3,861.63 ...

Power Stock, Power Grid Corporation of India Ltd has reported a 4.1% year-on-year (YoY) decline in net profit at Rs 3,861.6 crore for the third quarter that ended on December 31, 2024. In the ...

Copyright 2025 The Associated Press. All Rights Reserved. U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and ...

For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...

Ozempic becomes the first GLP-1 treatment option for people with type 2 diabetes and chronic kidney disease Mario Tama/Getty The Food and Drug Administration has approved Ozempic to reduce the ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval ...

The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram prescription pill ...